Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring.

Add to wishlist

Understanding Hematopoietic Progenitor Cells (HPCs)

Hematopoietic progenitor cells are immature cells capable of differentiating into various blood cell lineages. These cells are crucial for reconstituting the hematopoietic system in patients undergoing stem cell transplantation. HPCs are typically mobilized from the bone marrow into the peripheral blood using growth factors like granulocyte colony-stimulating factor (G-CSF), and their numbers are then monitored to determine the optimal timing for stem cell harvest.

Please inquire about this product by clicking
the following link

Enquiry This Applications

Importance of HPC Count Monitoring in PBSC Harvest

Optimal Timing for Stem Cell Collection:
Monitoring HPC counts in the peripheral blood is essential for determining the optimal timing for stem cell collection. Accurate and timely measurement of HPCs ensures that the collection is performed when their numbers are highest, maximizing the yield and effectiveness of the PBSC harvest.

Assessment of Mobilization Efficacy:
The efficacy of HPC mobilization can vary among individuals. Regular monitoring of HPC counts allows clinicians to assess the response to mobilization agents like G-CSF and adjust the treatment protocol if necessary. This ensures that an adequate number of progenitor cells are mobilized into the peripheral blood.

Predicting Collection Success:
Accurate HPC counts help predict the success of the PBSC collection process. By knowing the number of progenitor cells available in the peripheral blood, clinicians can estimate the total number of cells that will be collected, ensuring that the transplantation dose requirements are met.

Reducing Collection Procedures:
By optimizing the timing and predicting the success of the collection, HPC count monitoring can reduce the number of apheresis procedures needed to obtain the required cell dose. This minimizes the physical burden on the donor and reduces the overall cost and complexity of the PBSC harvest process.

Sysmex XE-2100 for HPC Count Monitoring

The Sysmex XE-2100 hematology analyzer is a state-of-the-art instrument that offers precise and reliable HPC count measurements. Key features of the Sysmex XE-2100 relevant to PBSC harvest monitoring include:

Advanced Flow Cytometry Technology:
The XE-2100 uses advanced flow cytometry technology to accurately identify and quantify HPCs in peripheral blood samples. This technology provides high sensitivity and specificity, ensuring reliable HPC measurements.

Automated and High-Throughput Analysis:
The XE-2100 is designed for automated, high-throughput analysis, making it suitable for routine use in clinical laboratories. Its automation capabilities reduce the potential for human error and increase the efficiency of HPC count monitoring.

Comprehensive Hematological Profiling:
In addition to HPC counts, the XE-2100 provides a comprehensive range of hematological parameters, allowing for a holistic assessment of the donor’s blood status. This comprehensive profiling supports informed decision-making during the PBSC harvest process.

User-Friendly Interface:
The XE-2100 features an intuitive and user-friendly interface, facilitating easy operation and interpretation of results by clinicians and laboratory technicians. This ensures that HPC count monitoring can be seamlessly integrated into clinical workflows.

The Sysmex XE-2100 hematology analyzer offers a reliable and efficient method for monitoring hematopoietic progenitor cell (HPC) counts during peripheral blood stem cell (PBSC) harvest. By providing accurate and timely HPC measurements, the XE-2100 helps optimize the timing of stem cell collection, assess mobilization efficacy, predict collection success, and reduce the number of collection procedures. Incorporating HPC count monitoring with the Sysmex XE-2100 into PBSC harvest protocols can significantly improve transplantation outcomes and enhance the overall efficiency of the stem cell collection process.